Achalasia: Comprehensive Clinical Review with Evidence-Based Management Strategies

Pathophysiology & Diagnostic Criteria Achalasia is a primary esophageal motility disorder rooted in neurodegenerative loss of inhibitory neurons (primarily nitric oxide– and VIP-producing) in the myenteric plexus of the lower…

Continue ReadingAchalasia: Comprehensive Clinical Review with Evidence-Based Management Strategies

Acute Cholangitis: Clinical Recognition, Severity Stratification, and Evidence-Based Management

Pathophysiology & Clinical Context Acute cholangitis is an acute bacterial infection of the biliary tree secondary to biliary obstruction (most commonly choledocholithiasis), leading to stasis, ascending infection, and systemic inflammation.…

Continue ReadingAcute Cholangitis: Clinical Recognition, Severity Stratification, and Evidence-Based Management

Acute Pancreatitis: Clinical Evaluation, Risk Stratification, and Evidence-Based Management

Definition & Pathophysiology Acute pancreatitis (AP) is an acute inflammatory process of the pancreas, characterized by autodigestion of pancreatic tissue due to premature activation of pancreatic enzymes (e.g., trypsinogen →…

Continue ReadingAcute Pancreatitis: Clinical Evaluation, Risk Stratification, and Evidence-Based Management

Chronic Pancreatitis: A Clinically Oriented Review with Emphasis on Diagnosis, Etiologic Workup, Complications, and Evidence-Based Management

Pathophysiology Overview Chronic pancreatitis (CP) is a progressive, irreversible inflammatory pancreatic disorder characterized histopathologically by: Fibrotic replacement of parenchyma Calcification (in ~75% of alcoholic CP) Ductal distortion (strictures, dilatation, stones)…

Continue ReadingChronic Pancreatitis: A Clinically Oriented Review with Emphasis on Diagnosis, Etiologic Workup, Complications, and Evidence-Based Management

Gastroesophageal Reflux Disease (GERD) – Diagnosis, Evaluation, and Management Based on Current Evidence-Based Guidelines

Definition & Pathophysiology GERD is a chronic, often relapsing disorder characterized by the reflux of gastric (and duodenal) contents—acid, bile, pepsin, and pancreatic enzymes—into the esophagus, pharynx, or larynx, resulting…

Continue ReadingGastroesophageal Reflux Disease (GERD) – Diagnosis, Evaluation, and Management Based on Current Evidence-Based Guidelines

Peptic Ulcer Disease – Pathophysiology, Diagnosis, and Evidence-Based Management

I. Definition & Pathophysiology Peptic ulcer disease (PUD) is characterized by localized defects in the gastroduodenal mucosa that extend through the muscularis mucosae, resulting from an imbalance between aggressive factors…

Continue ReadingPeptic Ulcer Disease – Pathophysiology, Diagnosis, and Evidence-Based Management

Evaluation and Management of Splenomegaly in Children—Integrating Current Evidence-Based Guidelines

I. Definition & Epidemiologic Context Splenomegaly is defined as a spleen that exceeds the 95th percentile for age- and sex-matched controls—typically: Transverse diameter >12 cm in adolescents Length >7.3 cm +…

Continue ReadingEvaluation and Management of Splenomegaly in Children—Integrating Current Evidence-Based Guidelines

Insulinoma — Diagnosis, Localization, Genetic Evaluation, and Management Based on Current Evidence and Guidelines

Epidemiology and Pathophysiology Insulinomas are rare, typically benign (85–90%), functioning pancreatic neuroendocrine tumors (pNETs) arising from β-cells of the islets of Langerhans. Incidence is ~1–2 cases per million person-years, with…

Continue ReadingInsulinoma — Diagnosis, Localization, Genetic Evaluation, and Management Based on Current Evidence and Guidelines

Hepatitis A Virus (HAV) Infection: Pathogenesis, Diagnosis, Management, and Prevention — Aligning with Current Guidelines and Evidence

Epidemiology and Burden of Disease Hepatitis A virus (HAV), a non-enveloped, positive-sense single-stranded RNA virus belonging to the Picornaviridae family (genus Orthohepatovirus), remains one of the most prevalent causes of…

Continue ReadingHepatitis A Virus (HAV) Infection: Pathogenesis, Diagnosis, Management, and Prevention — Aligning with Current Guidelines and Evidence

Hepatitis E Virus (HEV) Infection — Epidemiology, Diagnosis, and Management with Emphasis on Current Guidelines and Evidence-Based Approaches

Epidemiology and Global Burden Hepatitis E virus (HEV), a non-enveloped, positive-sense, single-stranded RNA virus belonging to the Hepeviridae family (genus Orthohepevirus, species HEV-A), is a globally significant cause of acute…

Continue ReadingHepatitis E Virus (HEV) Infection — Epidemiology, Diagnosis, and Management with Emphasis on Current Guidelines and Evidence-Based Approaches

Acute Hepatitis B Virus (HBV) Infection — Diagnosis, Risk Stratification, Management, and Transition to Chronic Disease

Authored for clinicians with emphasis on evidence-based practice, updated guidelines (AASLD 2018, EASL 2017/2024 updates), and practical decision-making tools. Epidemiology & Virology Primer (Clinician Refresher) HBV is a Hepadnaviridae family,…

Continue ReadingAcute Hepatitis B Virus (HBV) Infection — Diagnosis, Risk Stratification, Management, and Transition to Chronic Disease

Diagnosis and Management of Chronic Constipation in Adults – An Evidence-Based Perspective for Clinicians

Epidemiology and Clinical Significance Chronic functional constipation (CFC) affects approximately 12–27% of the general adult population, with prevalence rising sharply with age—up to 30–40% in individuals ≥65 years. It is…

Continue ReadingDiagnosis and Management of Chronic Constipation in Adults – An Evidence-Based Perspective for Clinicians

Giardiasis: Clinical Update with Evidence-Based Diagnostic and Therapeutic Strategies

Epidemiology & Pathogenesis Giardia lamblia (syn. G. duodenalis, G. intestinalis) is a flagellated protozoan parasite and a leading cause of protozoal gastroenteritis worldwide. The CDC estimates over 280 million cases…

Continue ReadingGiardiasis: Clinical Update with Evidence-Based Diagnostic and Therapeutic Strategies

Lactose Intolerance: Clinical Overview, Diagnostic Evaluation, and Evidence-Based Management—Updated for Primary Care and Gastroenterology Practice

Definition and Pathophysiology Lactose intolerance (LI) is a clinical syndrome characterized by the development of digestive symptoms following ingestion of lactose—the primary carbohydrate in mammalian milk. It results from lactose…

Continue ReadingLactose Intolerance: Clinical Overview, Diagnostic Evaluation, and Evidence-Based Management—Updated for Primary Care and Gastroenterology Practice

Microscopic Colitis: Etiology, Diagnosis, and Evidence-Based Management

Definition and Disease Spectrum Microscopic colitis (MC) is a chronic, immune-mediated inflammatory disorder of the colon characterized by persistent, non-bloody, watery diarrhea, with normal-appearing mucosa on endoscopy but distinctive histopathological…

Continue ReadingMicroscopic Colitis: Etiology, Diagnosis, and Evidence-Based Management